AI brief of an SEC Form 8-K · Innovex International (INVX)

Innovex shareholder Amberjack sells 5 million INVX shares in secondary offering

Neutral Impact 2 of 5 shareholder Written later

Innovex International entered an underwriting agreement with Amberjack Capital Partners affiliates and Barclays Capital for the sale of 5,000,000 common shares by the selling stockholders. The company sold no shares and received no proceeds, so the offering does not add new shares or cash to the company.

Key points

  • Selling stockholders are affiliates of Amberjack Capital Partners, L.P.; the company received no proceeds
  • 5,000,000 shares offered at a price to the underwriter of $28.71 per share
  • Underwriting agreement dated August 6, 2026; offering closed August 10, 2026
  • Offering made under an effective Form S-3 shelf registration (File No. 333-282178)

The filing

CompanyInnovex International (INVX)
Form8-K, current report
Filed with the SECAug 10, 2026, 4:47 PM ET
Accession number0001193125-26-342567

Items reported: 1.01 Material Definitive Agreement

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:55 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 10, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.